Skip to main content
. 2017 Aug 22;8(42):72363–72374. doi: 10.18632/oncotarget.20390

Table 3. Development of cloned embryos derived from the abnormal imprinting donor cells with H19 knockdown.

Group No. embryos (Rep.) No. embryos cleaved (% ± SEM) No. blastocysts (% ± SEM)
siRNA-control 171 (5) 135 (78.82 ± 1.91)a 22 (12.85 ± 1.37)a
siRNA-negative 184 (5) 146 (79.32 ± 1.73)a 21 (11.34 ± 1.28)a
siRNA-positive 173 (5) 151 (87.28 ± 1.85)b 48 (27.90 ± 1.84)b

a–bValues in the same column with different superscripts differ significantly (P < 0.05).